pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

NIH launches streamlined website consolidating 700 sites into eight thematic hubs

Oct 2, 2026·read at STAT ↗Positive

NIH announced a new version of its public website that reorganizes content from more than 700 separate sites into eight thematic hubs.

The hubs cover health, research, data, clinical studies, rare diseases, technology, cancer, and grants, shifting focus from individual institutes to topics that users typically search for.

Agency officials say the redesign aims to make trusted NIH information easier and faster to find, creating a more intuitive experience for the public and researchers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “NIH rolling out streamlined website to help public find information more easily”

read at STAT ↗
850 words · retrieved 3h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2National Institutes of HealthPATHUniversity of Pennsylvania
topics
Oncology2Rare Disease2CardiologyHeart Failure

related stories

  • 9h agoFoghorn cuts 40% of workforceBioSpace
  • Aug 20STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejectionSTAT
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jul 29STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drugSTAT
  • Apr 23Heart’s beat may help it beat cancer, mouse research suggestsSTAT